Drew Weissman
M.D., Ph.D.
Roberts Family Professor of Vaccine Research
👥Biography 个人简介
Drew Weissman collaborated with Katalin Karikó to develop modified mRNA technology that enabled COVID-19 vaccines and is now being applied to cancer. His laboratory continues to advance mRNA therapeutics for infectious diseases, cancer, and genetic disorders, with multiple programs in clinical development.
Drew Weissman与Katalin Karikó合作开发了修饰mRNA技术，使COVID-19疫苗成为可能，现在正被应用于癌症。他的实验室继续推进用于传染病、癌症和遗传疾病的mRNA治疗，多个项目正在临床开发中。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
mRNA Technology
Co-developed modified mRNA technology with Karikó.
Lipid Nanoparticles
Advanced LNP formulations for mRNA delivery.
Representative Works 代表性著作
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity
Molecular Therapy (2008)
Demonstration of improved mRNA translation with modifications.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
James M. Wilson
University of Pennsylvania
Guangping Gao
University of Massachusetts Chan Medical School
Federico Mingozzi
Spark Therapeutics / University of Paris
Feng Zhang
Broad Institute / MIT
关注 Drew Weissman 的研究动态
Follow Drew Weissman's research updates
留下邮箱，当我们发布与 Drew Weissman（University of Pennsylvania）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment